A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)

First published 11/10/2017

Last updated 14/03/2024

EU PAS number:

EUPAS21010

Study

Ongoing

Documents

Study protocol

Initial protocol

p11282 synopsis

English (96.74 KB - PDF)View document

Updated protocol

p11282-protocol-amendment4-synopsis

First published: 22/02/2024

English (102.35 KB - PDF)View document

Study results

Study report

Other information

Secondary tabs